-
公开(公告)号:US07576175B2
公开(公告)日:2009-08-18
申请号:US11140548
申请日:2005-05-26
申请人: Kit S. Lam , Ruiwu Liu , Li Peng
发明人: Kit S. Lam , Ruiwu Liu , Li Peng
IPC分类号: C07K5/08 , C07K5/10 , C07K7/04 , C07K7/08 , C07K14/00 , C07K1/00 , C07K1/107 , A61K38/06 , A61K38/07 , A61K38/08 , A61K38/10 , A61K38/16
CPC分类号: C07C275/42 , A61K38/00 , A61K45/06 , B82Y5/00 , B82Y10/00 , B82Y30/00 , C07K5/021 , C07K5/0815 , C07K5/1019 , C07K7/02 , Y02A50/401 , Y02A50/475
摘要: The present invention provides α4β1 integrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.
摘要翻译: 本发明提供显示高结合亲和力,特异性和稳定性的α4β1整联蛋白配体。 配体包含具有n个独立选择的氨基酸的肽,其中至少一个氨基酸是非天然氨基酸或D-氨基酸,并且其中n是3-20的整数。提供了用于给予 治疗癌症,炎性疾病和自身免疫性疾病。 还提供了施用用于成像受试者的肿瘤,器官或组织的配体的方法。
-
公开(公告)号:US20100310455A1
公开(公告)日:2010-12-09
申请号:US12440219
申请日:2007-09-07
申请人: Richard D. Carpenter , Mirela Andrei , Ruiwu Liu , Kit S. Lam , Mark J. Kurth
发明人: Richard D. Carpenter , Mirela Andrei , Ruiwu Liu , Kit S. Lam , Mark J. Kurth
IPC分类号: A61K51/08 , C07K5/08 , C07K5/10 , A61K38/06 , A61K38/07 , A61K9/127 , A61K49/00 , A61P35/02 , A61P37/02 , A61P29/00
CPC分类号: A61K51/0459 , A61K9/0014 , A61K9/0019 , A61K51/0453 , A61K51/0455 , Y02A50/401 , Y02A50/475
摘要: The present invention provides α4β1 integrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.
摘要翻译: 本发明提供显示高结合亲和力,特异性和稳定性的α4和bgr1整联蛋白配体。 配体包含具有n个独立选择的氨基酸的肽,其中至少一个氨基酸是非天然氨基酸或D-氨基酸,并且其中n是3-20的整数。提供了用于给予 治疗癌症,炎性疾病和自身免疫性疾病。 还提供了施用用于成像受试者的肿瘤,器官或组织的配体的方法。
-
公开(公告)号:US09119884B2
公开(公告)日:2015-09-01
申请号:US13820362
申请日:2012-01-19
申请人: Kit S. Lam , Ruiwu Liu , Wei Yao , Nancy Lane
发明人: Kit S. Lam , Ruiwu Liu , Wei Yao , Nancy Lane
IPC分类号: A61K38/00 , A61P19/08 , A61P19/02 , A61P19/10 , A61K38/10 , A61K38/16 , A61K38/08 , A61K38/06 , A61K38/07 , A61K38/04 , C07K5/00 , C07K7/00 , C07K16/00 , C07K17/00 , A61K47/48 , A61K31/663 , C07K7/06 , A61K31/66 , C07F9/02 , A61K31/00 , A61K31/661 , C07K5/09 , C07K5/103 , C07K5/107 , C07K5/11
CPC分类号: C07K5/0821 , A61K31/00 , A61K31/66 , A61K31/661 , A61K31/663 , A61K35/28 , A61K38/00 , A61K38/06 , A61K38/08 , A61K38/10 , A61K47/548 , A61K47/64 , C07F9/02 , C07K5/0817 , C07K5/101 , C07K5/1016 , C07K5/1019 , C07K7/06
摘要: The present invention provides compounds and pharmaceutical compositions of a peptidomimetic ligand, e.g. LLP2A, conjugated with a bisphosphonate drug, e.g. Alendronate. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of osteoporosis and for the promotion of bone growth due to their specificity for the α4β1 integrin on mesenchymal stem cells and for the surface of bone.
摘要翻译: 本发明提供了肽模拟配体的化合物和药物组合物,例如 与双膦酸盐药物缀合的LLP2A,例如 阿仑膦酸盐 本发明的化合物和药物组合物可用于治疗骨质疏松症和促进骨生长,因为它们对间充质干细胞和骨表面上的α4和bgr1整联蛋白的特异性。
-
公开(公告)号:US08486370B2
公开(公告)日:2013-07-16
申请号:US12440219
申请日:2007-09-07
申请人: Richard D. Carpenter , Mirela Andrei , Ruiwu Liu , Kit S. Lam , Mark J. Kurth
发明人: Richard D. Carpenter , Mirela Andrei , Ruiwu Liu , Kit S. Lam , Mark J. Kurth
IPC分类号: A61K51/00
CPC分类号: A61K51/0459 , A61K9/0014 , A61K9/0019 , A61K51/0453 , A61K51/0455 , Y02A50/401 , Y02A50/475
摘要: The present invention provides α4β1 integrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.
摘要翻译: 本发明提供显示高结合亲和力,特异性和稳定性的α4β1整联蛋白配体。 配体包含具有n个独立选择的氨基酸的肽,其中至少一个氨基酸是非天然氨基酸或D-氨基酸,并且其中n是3-20的整数。提供了用于给予 治疗癌症,炎性疾病和自身免疫性疾病。 还提供了施用用于成像受试者的肿瘤,器官或组织的配体的方法。
-
公开(公告)号:US20100021379A1
公开(公告)日:2010-01-28
申请号:US12306244
申请日:2007-06-28
CPC分类号: A61K47/6835 , A61K47/62 , A61K47/646
摘要: The present invention provides antibody conjugates comprising a targeting agent covalently attached to an antibody or fragment thereof. The antibody conjugates of the present invention are particularly useful for imaging a tumor, organ, or tissue and for treating diseases and disorders such as cancer, inflammatory diseases, autoimmune diseases, infectious diseases, and neurological disorders. Kits containing the antibody conjugates described herein find utility in a wide range of applications including, for example, in vivo imaging and immunotherapy.
摘要翻译: 本发明提供了包含与抗体或其片段共价连接的靶向试剂的抗体缀合物。 本发明的抗体缀合物特别可用于成像肿瘤,器官或组织并用于治疗诸如癌症,炎性疾病,自身免疫疾病,感染性疾病和神经障碍的疾病和病症。 含有本文所述的抗体缀合物的试剂盒可用于广泛的应用,包括例如体内成像和免疫治疗。
-
公开(公告)号:US20140056855A1
公开(公告)日:2014-02-27
申请号:US13820362
申请日:2012-01-19
申请人: Kit S. Lam , Ruiwu Liu , Wei Yao , Nancy Lane
发明人: Kit S. Lam , Ruiwu Liu , Wei Yao , Nancy Lane
CPC分类号: C07K5/0821 , A61K31/00 , A61K31/66 , A61K31/661 , A61K31/663 , A61K35/28 , A61K38/00 , A61K38/06 , A61K38/08 , A61K38/10 , A61K47/548 , A61K47/64 , C07F9/02 , C07K5/0817 , C07K5/101 , C07K5/1016 , C07K5/1019 , C07K7/06
摘要: The present invention provides compounds and pharmaceutical compositions of a peptidomimetic ligand, e.g. LLP2A, conjugated with a bisphosphonate drug, e.g. Alendronate. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of osteoporosis and for the promotion of bone growth due to their specificity for the α4β1 integrin on mesenchymal stem cells and for the surface of bone.
摘要翻译: 本发明提供了肽模拟配体的化合物和药物组合物,例如 与双膦酸盐药物缀合的LLP2A,例如 阿仑膦酸盐 本发明的化合物和药物组合物可用于治疗骨质疏松症和促进骨生长,因为它们对间充质干细胞和骨表面上的α4β1整联蛋白的特异性。
-
公开(公告)号:US20110301192A1
公开(公告)日:2011-12-08
申请号:US13119152
申请日:2009-09-29
申请人: Robert Weiss , See-Hyoung Park , Kit S. Lam , Ruiwu Liu
发明人: Robert Weiss , See-Hyoung Park , Kit S. Lam , Ruiwu Liu
IPC分类号: A61K31/454 , C07D235/18 , C07D403/06 , A61P35/00 , C07D401/04 , A61K31/4184 , A61K31/4375 , C07D401/06 , C07D455/02
CPC分类号: C07D401/04 , C07D235/18 , C07D401/06 , C07D401/14 , C07D403/12 , C07D405/14 , C07D455/02
摘要: The present invention provides compounds that inhibit cyclin kinase inhibitor p21, such as compounds of formula I. The present invention also provides compositions including compounds of Formula I and a pharmaceutically acceptable excipient. In addition, the present invention provides methods of inhibiting cyclin kinase inhibitor p21 and of treating cancer.
摘要翻译: 本发明提供了抑制细胞周期蛋白激酶抑制剂p21的化合物,例如式I化合物。本发明还提供包含式I化合物和药学上可接受的赋形剂的组合物。 此外,本发明提供了抑制细胞周期蛋白激酶抑制剂p21和治疗癌症的方法。
-
公开(公告)号:US08168800B2
公开(公告)日:2012-05-01
申请号:US12740329
申请日:2008-10-31
申请人: Lee-Way Jin , Kit S. Lam , Ruiwu Liu , Hyun-Seok Hong , Izumi Maezawa
发明人: Lee-Way Jin , Kit S. Lam , Ruiwu Liu , Hyun-Seok Hong , Izumi Maezawa
IPC分类号: C07D491/052
CPC分类号: C07D491/052 , A61K51/041 , A61K51/0453 , A61K51/0455 , A61K51/0463 , C07B2200/05
摘要: In one aspect, the present invention provides for compounds and labeled compounds of Formula I, and pharmaceutical compositions thereof. In another aspect, the present invention provides for methods of using compounds or labeled compounds of Formula I for various therapeutic and imaging purposes, including, but not limited to, treating Alzheimer's disease in patient and imaging Aβ peptide aggregates in a patient.
摘要翻译: 一方面,本发明提供式I化合物和标记的化合物及其药物组合物。 另一方面,本发明提供了使用式I化合物或标记化合物用于各种治疗和成像目的的方法,包括但不限于在患者和成像中治疗阿尔茨海默氏病A&bgr; 肽聚集体在患者体内。
-
公开(公告)号:US20110071301A1
公开(公告)日:2011-03-24
申请号:US12740329
申请日:2008-10-31
申请人: Lee-way Jin , Kit S. Lam , Ruiwu Liu , Hyun-Seok Hong , Izumi Maezawa
发明人: Lee-way Jin , Kit S. Lam , Ruiwu Liu , Hyun-Seok Hong , Izumi Maezawa
IPC分类号: C07D491/052
CPC分类号: C07D491/052 , A61K51/041 , A61K51/0453 , A61K51/0455 , A61K51/0463 , C07B2200/05
摘要: In one aspect, the present invention provides for compounds and labeled compounds of Formula I, and pharmaceutical compositions thereof. In another aspect, the present invention provides for methods of using compounds or labeled compounds of Formula I for various therapeutic and imaging purposes, including, but not limited to, treating Alzheimer's disease in patient and imaging Aβ peptide aggregates in a patient.
摘要翻译: 一方面,本发明提供式I化合物和标记的化合物及其药物组合物。 另一方面,本发明提供了使用式I化合物或标记化合物用于各种治疗和成像目的的方法,包括但不限于在患者和成像中治疗阿尔茨海默氏病A&bgr; 肽聚集体在患者体内。
-
公开(公告)号:US20060019900A1
公开(公告)日:2006-01-26
申请号:US11140548
申请日:2005-05-26
CPC分类号: C07C275/42 , A61K38/00 , A61K45/06 , B82Y5/00 , B82Y10/00 , B82Y30/00 , C07K5/021 , C07K5/0815 , C07K5/1019 , C07K7/02 , Y02A50/401 , Y02A50/475
摘要: The present invention provides α4β1 integrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.
摘要翻译: 本发明提供了表现出高结合亲和力,特异性和稳定性的α4AT1A整联蛋白配体。 配体包含具有n个独立选择的氨基酸的肽,其中至少一个氨基酸是非天然氨基酸或D-氨基酸,并且其中n是3-20的整数。提供了用于给予 治疗癌症,炎性疾病和自身免疫性疾病。 还提供了用于施用用于成像受试者的肿瘤,器官或组织的配体的方法。
-
-
-
-
-
-
-
-
-